128 results
8-K
LFCR
Lifecore Biomedical Inc
7 Jun 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
., a Delaware corporation (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock
8-K
LFCR
Lifecore Biomedical Inc
14 May 24
Entry into a Material Definitive Agreement
5:04pm
Determination (the “Staff Determination”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that Nasdaq
8-K
EX-10.1
LFCR
Lifecore Biomedical Inc
14 May 24
Entry into a Material Definitive Agreement
5:04pm
; provided, that Obligations of a Loan Party shall not include its Excluded Swap Obligations. “OFAC” means the United States Department of Treasury … . “Protective Advance” has the meaning specified in Section 2.01(c)(ii)(A). “PTE” means a prohibited transaction class exemption issued by the U.S. Department
8-K
LFCR
Lifecore Biomedical Inc
19 Apr 24
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
4:34pm
, Inc., a Delaware corporation (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq
8-K
EX-99.1
LFCR
Lifecore Biomedical Inc
19 Apr 24
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
4:34pm
”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its
8-K
EX-10.3
f45nqj r4qetcf09v
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
8-K
EX-99.1
nz7w6a
16 Feb 24
Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
4:12pm
8-K
ietwk
16 Feb 24
Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
4:12pm
8-K
EX-99.1
j66h0 k1p
12 Jan 24
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
4:51pm
8-K
lw22 77eglk9
12 Jan 24
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
4:51pm
8-K
3b05scc3o3low5yfc4n3
20 Nov 23
Regulation FD Disclosure
4:09pm
8-K
EX-99.1
3w9if41n
20 Nov 23
Regulation FD Disclosure
4:09pm
8-K
qz21i
18 Oct 23
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
4:07pm
8-K
EX-99.1
2a66sb u3
18 Oct 23
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
4:07pm
8-K
ttxf70ylrl1rso
22 Aug 23
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
4:11pm
8-K
EX-99.1
l99tirg1jawz 8j63orq
22 Aug 23
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
4:11pm
8-K
EX-10.1
svb4u 30xgmi3ah8tjr
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.6
wq83y85n bovq
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm